Castle Biosciences, Inc. - Common stock (CSTL) — AI analysis & news
Castle Biosciences, Inc. - Common stock (CSTL) stock: 5 recent news items, neutral aggregate sentiment, AI analysis and market context on BestAIBroker.
Current sentiment read
Across the last 5 indexed CSTL stories, aggregate finance-aware sentiment is neutral (+0.00 on a -1 to +1 scale).
Latest CSTL news
- Castle Biosciences CCO Tobin sells $110,608 in stock By Investing.com - Investing.com India · Investing.com India
- Castle Biosciences CCO Tobin sells $110,608 in stock By Investing.com - Investing.com UK · Investing.com UK
- Silicon Valley billionaires are obsessed with 'reprogramming' their bodies for longevity. The first human trial suggests they may be onto something. · Business Insider
- Castle Biosciences CEO sells $512k in stock - Investing.com India · Investing.com India
- Why is Alamar Biosciences stock surging today? - Investing.com · Investing.com
FAQ
What is the current sentiment for CSTL stock?
Aggregate finance-aware sentiment across the last 5 indexed CSTL news stories is neutral (+0.00 on a -1 to +1 scale).